Showing results (4651-4660 of 9,342) with videos related to
Sort By:
Pageof 935
Cancer Medicine|September 7, 2026
Single-Cell Transcriptome of Anaplastic Thyroid Cancer Reveals Immunosuppressive Tumor Microenvironment RemodelingSaeko Tahara, Akiko Iguchi-Manaka, Naoto Takeuchi, et al.Cancer Medicine|September 7, 2026
A U-Shaped Association: The First-Year eGFR Slope and Mortality Risk in Multiple MyelomaLian Li, Xiang Liu, Mingjing Guan, et al.Cancer Medicine|September 29, 2026
Multi-Center Evaluation of Opioid Administration or Prescription in Pediatric Oncology Patients Using the OMOP CDMYuqing Feng, Martin Yi, Catherine C Aftandilian, et al.Cancer Medicine|September 28, 2026
Unveiling the Prognostic Power of Circulating Tumor DNA in Multiple Myeloma: A Systematic Review and Updated Meta-AnalysisWanting Ying, Lei Fan, Ran Li, et al.Cancer Medicine|September 27, 2026
Pan-Cancer Analysis of the Immunomodulatory Roles and Prognostic Value of PDXP and Experimental Verification in SKCMYingjian Hu, Xinzhu Zeng, Wei Cao, et al.Cancer Medicine|September 30, 2026
Clinicopathological Features and Exploratory Outcome Associations of Bone Marrow Fibrosis in Newly Diagnosed Acute Lymphoblastic Leukemia: A Single-Center Retrospective Cohort StudyYing Chen, Si-Heng Liu, Cen-Xia Ran, et al.Cancer Medicine|October 7, 2026
CO-Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy DecisionsHans C Hasselbalch, Morten Kranker Larsen, Lea Løffler, et al.Cancer Medicine|October 7, 2026
Age-Dependent Patterns of Cisplatin-Induced Ototoxicity in Head and Neck Cancer: A Longitudinal Audiologic AnalysisC Suzuki, Y Kishimoto, M Yamamoto, et al.Cancer Medicine|October 13, 2026
The Association Between CD40 rs1883832 Polymorphism and Cancer Susceptibility: A Systematic Review and Meta-AnalysisBingxiang Wang, Min Gao, Shuhao Fan, et al.Cancer Medicine|October 13, 2026
Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and AptamersMobina Darabi, Zeynab Zahedi, Kosar Zolfaghari, et al.Pageof 935